XML 28 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Collaboration Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Revenue related to research and clinical development activities $ 1,020 $ 2,043 $ 7,211 $ 5,929
Seattle Genetics [Member]        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Revenue related to research and clinical development activities 1,000 $ 2,000 7,200 $ 5,900
Deferred revenue 14,700   14,700  
Remaining performance obligation related to two product candidates $ 40,700   $ 40,700